Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Recommendation of “Hold” by Brokerages

Teladoc Health, Inc. (NYSE:TDOC) has been assigned a consensus recommendation of “Hold” from the eighteen ratings firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating and five have given a buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $7.5313.

Several research firms have recently weighed in on TDOC. TD Cowen dropped their price target on shares of Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a research note on Thursday, February 26th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Teladoc Health in a research report on Friday, March 27th. Bank of America raised shares of Teladoc Health from a “neutral” rating to a “buy” rating and set a $7.00 price objective for the company in a research report on Thursday, February 26th. Stifel Nicolaus lowered their price objective on shares of Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a research report on Thursday, February 26th. Finally, Barclays lowered their price objective on shares of Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating for the company in a research report on Thursday, March 26th.

Teladoc Health Stock Performance

Teladoc Health stock opened at $6.55 on Friday. The firm has a 50 day simple moving average of $5.83 and a 200-day simple moving average of $6.25. Teladoc Health has a 1-year low of $4.40 and a 1-year high of $9.77. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.80 and a quick ratio of 2.72. The stock has a market cap of $1.18 billion, a price-to-earnings ratio of -6.75 and a beta of 2.08.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.01). Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The firm had revenue of $613.85 million during the quarter, compared to analysts’ expectations of $611.04 million. During the same period last year, the company earned ($0.53) EPS. The business’s quarterly revenue was down 2.5% on a year-over-year basis. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. On average, analysts expect that Teladoc Health will post -0.92 EPS for the current year.

Insider Buying and Selling at Teladoc Health

In related news, CEO Charles Divita III sold 27,731 shares of the stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $5.49, for a total transaction of $152,243.19. Following the completion of the transaction, the chief executive officer owned 364,784 shares of the company’s stock, valued at approximately $2,002,664.16. This trade represents a 7.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

A number of hedge funds have recently made changes to their positions in TDOC. Allianz Asset Management GmbH lifted its holdings in Teladoc Health by 189.2% during the 3rd quarter. Allianz Asset Management GmbH now owns 1,619,391 shares of the health services provider’s stock worth $12,518,000 after buying an additional 1,059,458 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Teladoc Health by 4.2% during the 3rd quarter. Vanguard Group Inc. now owns 21,910,950 shares of the health services provider’s stock worth $169,372,000 after buying an additional 891,732 shares in the last quarter. Jupiter Asset Management Ltd. acquired a new stake in Teladoc Health during the 3rd quarter worth approximately $7,576,000. Tejara Capital Ltd acquired a new stake in Teladoc Health during the 4th quarter worth approximately $1,114,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al lifted its holdings in Teladoc Health by 62.3% during the 4th quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 243,525 shares of the health services provider’s stock worth $1,705,000 after buying an additional 93,450 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.